Sunday, August 31, 2014

Top 5 Life Sciences Companies To Buy Right Now

With shares of Corning (NYSE:GLW) trading around $17, is GLW an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework.

T = Trends for a Stock’s Movement

Corning produces and sells specialty glasses, ceramics, and related materials worldwide. It operates in five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences. Corning has launched Corning Lotus Glass, an environmentally friendly display glass for organic LED and LCD displays that are used in portable devices such as smartphones, tablets, and notebook computers. Smart phones, tablets, notebook computers, and their related materials are seeing explosive growth in developed and developing countries around the world.

Corning on Tuesday announced its results for the fourth quarter and full year of 2013.�Core earnings per share were 29 cents, an increase of 4 percent over last year�� fourth quarter and better than expected. GAAP earnings per share were 30 cents.�Core sales were $2 billion, a 2 percent decline from the comparable period last year.��013 was a very successful year for Corning,��Wendell P. Weeks, chairman, chief executive officer, and president, said in the earnings report. ��e achieved the company�� primary performance goal of restoring earnings growth. This was accomplished by regaining positive momentum in our LCD business and growing the earnings in our other segments. We also delivered on our commitment to enhance shareholder value by increasing the cash dividend and executing more than $1.5 billion in share repurchases. The company�� performance was recognized by a 41% improvement in the year�� share price, a result with which we are delighted.��/p>

Best Cheap Stocks To Own Right Now: Horsehead Holding Corp.(ZINC)

Horsehead Holding Corp., together with its subsidiaries, produces and sells specialty zinc and zinc-based products in North America. The company?s products include PW zinc metal, which is used to provide a protective coating to various fabricated products, including pipe and guard rails, heat exchangers, and telecommunications towers, as well as for the production of brass; and SSHG zinc metal that is used as feed for the manufacture of high-purity zinc powder and zinc alloys. It also offers zinc oxide for the production of tire and rubber products, chemicals, ceramics, plastics, paints, lubricating oils, and pharmaceuticals. In addition, the company recycles electric arc furnace dust, a hazardous waste generated by steel mini-mills. Further, it provides special zinc powders, which are used in general chemical and metallurgical applications, as well as in friction applications, such as brake linings for automobiles; battery grade zinc powders that are used in alkaline, me rcuric oxide, silver oxide, and zinc-air batteries; and copper-based powders, including brass, bronze, and nickel-silver powders, which are used in various applications comprising brazing, infiltrating, and powdered metallurgical hardware, such as lock bodies, valves, and gears. Additionally, the company offers short-line railroad service for the movement of materials. It primarily serves galvanizers and brass producers; alkaline battery industries; and manufacturers of tire and rubber products, lubricating oils, chemicals, paints, ceramics, plastics, and pharmaceuticals. The company was incorporated in 2003 and is based in Pittsburgh, Pennsylvania.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Basic materials shares jumped about 1.72 percent in Monday's trading. Leading the sector was strength from Century Aluminum Co (NASDAQ: CENX) and Horsehead Holding (NASDAQ: ZINC). In trading on Monday, utilities shares dropped by 0.13 percent.

  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Basic materials shares jumped about 1.72 percent in Monday's trading. Leading the sector was strength from Century Aluminum Co (NASDAQ: CENX) and Horsehead Holding (NASDAQ: ZINC). In trading on Monday, utilities shares dropped by 0.13 percent.

Top 5 Life Sciences Companies To Buy Right Now: Robogroup TEK Ltd (ROBO)

RoboGroup T.E.K Ltd. is a global, diversified enterprise with proprietary technologies on the forefront of robotics, motion control and technology education. RoboGroup's activities are organized in two related business operations: Yaskawa Eshed Technology (YET) and Intelitek.

YET, a joint venture with Japan's Yaskawa Electric Corp., which provides industrial motion controls, particularly those based on its algorithms. Intelitek, which develops, manufactures and markets training products and e-learning systems. Intelitek�� broad educational product line covers subjects such as computer-aided design, computer-aided manufacturing, configurable network computing, robotics, machine vision, hydraulics, pneumatics, sensors, process control and data acquisition. Intelitek also designs and produces integrated and customized manufacturing workcells, ranging from small-scale flexible manufacturing systems to complete computer integrated manufacturing systems.

Advisors' Opinion:
  • [By John Udovich]

    Spruce Point Capital Management, LLC has released a research report about small cap robotics stock iRobot Corporation (NASDAQ: IRBT) entitled ��bout to Short Circuit,��meaning investors should take a closer look at the report, the�stock�and the performance of�robotics peer Adept Technology Inc (NASDAQ: ADEP) and�the Robo-Stox Global Robotics & Automation ETF (NASDAQ: ROBO). I should mention that we used to have both Adept Technology and iRobot Corporation in our SmallCap Network Elite Opportunity (SCN EO) portfolio�because we see the�robotics subsector improving as companies aim to reduce overhead and improve efficiencies through machine to machine (M2M) automation.

  • [By Matt Krantz]

    Another way for investors to play the robotics industry is a new exchange traded fund, Robo-Stox Robotics & Automation (symbol: ROBO). The ETF owns a basket of robotics and automation stocks. One major caution, though, is that not all the stocks in the ETF are those investors traditionally think of when it comes to robotics. The largest weighting is in 3D Systems, a maker of a 3D printer, and Faro Technologies, which makes measurement devices. But none of the stocks in the ETF account for more than 4% of the total value, so the diversification helps give investors a way to play the speculative industry.

Top 5 Life Sciences Companies To Buy Right Now: Light SA (LIGT3)

Light SA, formerly TRIAL Participacoes SA, is a Brazil-based holding company primarily involved in the energy sector. Light SA is a parent of the Light Group. The Company operates through four segments, such as Power Distribution, Power Generation, Power Trading and Others, through which the Company is engaged in the generation, transmission, distribution and marketing of electric power and other related services. The Company distributes energy to approximately 31 municipalities in the state of Rio de Janeiro. Additionally, the Company is engaged in the manufacture of two-wheeled electric vehicles. The Company operates through subsidiaries, such as Light Servicos de Eletricidade SA, CR Zongshen E Power Fabricadora de Veiculos SA, Light Energia SA, Lightger SA, Itaocara Energia Ltda, Amazonia Energia SA, Light Esco Prestacaoo de Servicos SA, Lightcom Comercializadora de Energia SA, Light Solucoes em Eletricidade Ltda, Axxiom Solucoes Tecnologicas SA and Instituto Light. Advisors' Opinion:
  • [By Ney Hayashi]

    Oil company Petroleo Brasileiro SA (PETR4) contributed the most to the gauge�� advance as crude climbed. BR Properties SA rose the most since July 2012 after saying it will buy back shares. Phone company Tim Participacoes SA rebounded from a five-week low. Power utility Light SA (LIGT3) rallied after posting third-quarter earnings that beat analysts��estimates.

Top 5 Life Sciences Companies To Buy Right Now: Guggenheim CurrencyShares Euro Trust (FXE)

Guggenheim CurrencyShares Euro Trust, formerly CurrencyShares Euro Trust, is a grantor trust. The Trust issues shares (the Shares) in blocks of 50,000 (a Basket) in exchange for deposits of euro and distributes euro in connection with the redemption of Baskets. The investment objective of the Trust is for the Shares to reflect the price of euro plus accrued interest. The Shares are intended to offer investors an opportunity to participate in the market for the euro through an investment in securities. The Shares are bought and sold on NYSE Arca. The Shares are backed by the assets of the Trust, which does not hold or use derivative products. The Trust holds euro and, from time to time, issues Baskets in exchange for deposits of euro and distributes euro in connection with redemptions of Baskets.

The Sponsor is Rydex Specialized Products LLC. The Bank of New York Mellon serves as the Trustee. JPMorgan Chase Bank, N.A., London Branch is the Depository. The Depository maintains two deposit accounts for the Trust, a primary deposit account which may earn interest and a secondary deposit account which does not earn interest (Deposit Accounts). The secondary deposit account is used to account for interest received and paid out on creations and redemptions of Baskets. The secondary account is also used to account for interest, if any, earned on the primary deposit account, pay Trust expenses and distribute any excess interest to Shareholders on a monthly basis.

Advisors' Opinion:
  • [By Richard Cox]

    Elsewhere, similar market reactions could were seen after last week's monetary policy meeting at the European Central Bank [ECB]. The ECB also did little to signal changes to its own stimulus programs, which was not a total surprise, given the fact that the bank reduced interest rates by 25 basis points to new all-time lows at 0.75% at last month's meeting. The main potential for surprise, however, came from the possibility that the central bank would announce the implementation of negative interest rates (the rate paid to commercial banks when holding money). Since this would have been a bearish outcome for the EUR/USD, markets have since bought the Euro, pushing the CurrencyShares Euro Trust ETF (FXE) higher.

  • [By Ben Levisohn]

    The euro has dropped about 0.8% against the dollar, while the CurrencyShares Euro Trust ETF (FXE) has dropped 0.7% to $136.71 and the Currency Shares Japanese Yen Trust ETF (FXY) has fallen 1%. The ProShares UltrasShort Euro ETF (EUO) has gained 1.3% to $16.77, while the ProShares UltraShort Yen (YCS) has gained 1.9% to $66.58.

Saturday, August 30, 2014

Top 5 Transportation Companies For 2015

Top 5 Transportation Companies For 2015: FedEx Corporation(FDX)

FedEx Corporation provides transportation, e-commerce, and business services in the United States and internationally. It operates in four segments: FedEx Express, FedEx Ground, FedEx Freight, and FedEx Services. The FedEx Express segment offers various shipping services for the delivery of packages and freight. This segment also provides international trade services specializing in customs brokerage, and ocean and air freight forwarding services; customs clearance services, as well as global trade data, an information tool that allows customers to track and manage imports; and international trade advisory services, including assistance with the customs-trade partnership against terrorism program, as well as publishes customs duty and tax information in various customs areas. In addition, it offers supply chain solutions, including critical inventory logistics, transportation management, fulfillment, and fleet services. The FedEx Ground segment provides business and reside ntial ground package delivery services. It primarily serves customers in the small-package market in North America. The FedEx Freight segment offers less-than-truckload freight services, as well as freight-shipping services. As of May 31, 2010, this segment operated approximately 60,000 vehicles and trailers from a network of 492 service centers. The FedEx Services segment provides sales, marketing, information technology support, and customer service support services; and access to copying and digital printing through retail and Web-based platforms, signs and graphics, professional finishing, computer rentals, and a range of ground shipping and time-definite express shipping services. The company was founded in 1971 and is headquartered in Memphis, Tennessee.

Advisors' Opinion:
  • [By DailyFinance Staff]

    Investors took a wait-and-see attitude Tuesday, but airline stocks lost altitude. The market is in a holding pattern until! 2 p.m. Wednesday, when the Fed reveals details of this week's FOMC policy meetings, and whether it's ready to begin cutting back on its main economic stimulus program. If it does begin to taper, the next debate will begin immediately: Is that good or bad for investors? On Wall Street today, the Dow Jones industrial average (^DJI) edged down 9 points, the Nasdaq composite (^IXIC) fell nearly 6, and the Standard & Poor's 500 index (^GPSC) lost 5 points. The Dow's gainers were led by a pair of companies hiking their dividends. 3M (MMM), which makes everything from Post-It notes to medical equipment, rose 3 percent after increasing its payout by 35 percent. And Boeing (BA) rose 1 percent. It boosted the dividend by 50 percent and announced a big stock buyback. The other big blue chip winner was Visa (V), which gained another 2.5 percent. Its stock is now up 43 percent from a year ago. On the downside, Verizon (VZ), IBM (IBM), McDonald's (MCD) and Microsoft (MSFT) all lost about one percent. Microsoft says it will not name a new CEO until next year. And airline stocks were broadly lower. United (UAL) and Delta (DAL) both fell 3 percent. American Airlines (AAL), which completed its merger with U.S. Airways last week, fell 2 percent. And Southwest (V) also lost 2 percent. Brokerage recommendations gave a boost to several issues. Data storage companies Seagate (STX), up 3 percent, and Western Digital (WDC), up 2.5 percent, following JP Morgan upgrades. And iRobot (IRBT) surged 17 percent after Raymond James gave it a 'strong buy.' Shares of Facebook (FB) rose 2 percent, hitting an all-time high. The social media giant is rolling out new video ads this week. That's expected to boost revenue. The question is, will it alienate users? On the downside, Targacept (TRGT) lost more than a third of its value. A clinical trial of its schizophreni

  • [By Holly LaFon]

    Company Dell Inc. (DELL) Chesapeake Energy (CHK) DirecTV (DTV) Loews (L) Walt Disney (DIS) Aon Plc (AON) The Travelers Compa! nies (TRV! ) Level 3 Communications (LVLT) FedEx (FDX) Bank of New York Mellon (BK)
    Learn more about Mason and his views on the present economy in his second-quarter letter here. See his portfolio here.

  • [By Brian O'Connell]

    Investing Daily analysts have been bullish on FedEx Corp (NYSE: FDX) and current indicators show that a positive sentiment is still appropriate for the company.

    See here and herefor more background on Federal Express from experts.

    Finding good stocks like FDX is becoming paramount, as winter gives way to spring. The S&P 500 is only up by one percent so far this year, and thats after a plunge of negative 5.5 percent in January. Geopolitical upheaval in the Ukraine, high debt in key emerging market countries like China, and a sluggish US jobs market are all pulling down the US stock market right now.

    In an interview with this week, Dan Veru, Palisade Capital Management’s chief investment officer, says he expects the stock market to hold its uneven performance for three to six months.

    But FDX is showing all the signs of being the exception to the rule, and should see its stock price (about $137 per share this week) to rise above $155 per share this year. How so?

    Take the companys third-quarter financials. The firm doesnt post its Q3 revenues until Wednesday, March 19, but theres enough data out there to show that Fed Ex has survived a rough winter and is poised for upward growth for the remainder of the year.

    The third quarter was a wild one for the nations second-largest shipping service. It included the all-important holiday shopping season, which wasn’t kind to Fed Ex and its arch rival UPS (NYSE: UPS), the top shipping services company in the US. The season included the worst winter weather conditions in years, which impacted the ability of delivery companies to ship client packages.

    Still, the news looks upbeat for Fed Ex. Heres what the company is expecting from it! s own fin! ancial projections:

  • [By Paul Ausick]

    FedEx Corp. (NYSE: FDX) reported fiscal third-quarter 2014 results before markets opened Wednesday. The package delivery services provider reported diluted earnings per share (EPS) of $1.23 on revenues of $11.3 billion. In the same period a year ago, FedEx reported adjusted EPS of $1.23 on revenue of $11.0 billion. Third-quarter results also compare to the Thomson Reuters consensus estimates for EPS of $1.46 and $11.43 billion in revenue.

  • source from Top Penny Stocks For 2015:

Friday, August 29, 2014

Top 10 Biotech Stocks To Buy Right Now

You��e probably never heard of Arch Therapeutics (ARTH.OB), but if the last month is any indication of what�� to come, you most likely will know the name by this time next year.

Biotech Breakout Stars

It seems that every year there is a number of biotech stocks that apparently come from nowhere to produce large annual gains. As fate would have it, these are often market laggards in the year prior. Then, all of a sudden, the perfect combination of catalysts, perhaps an oversold stock, and a little bit of hope leads to large gains.

To explain, check out a few examples:

Peregrine Pharmaceuticals (PPHM) traded from $2.40 to $0.93 in 2011. Then in 2012, the stock recovered rallying to highs over $5.00.

Threshold Pharmaceuticals (THLD) did virtually nothing in 2011, ending the year at $1.30, but then soared to over $9.00 the following year. In 2013, Inovio (INO) was similar, as it had been dead money for years, but then produced a one-year 485% gain in 2013.

5 Best Wireless Telecom Stocks For 2015: Gentium SpA(GENT)

Gentium S.p.A., a biopharmaceutical company, focuses on the development and manufacture of its primary product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded DNA extracted from pig intestines. It develops defibrotide for the treatment and prevention of hepatic veno-occlusive disease (VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. The company has completed a Phase III clinical trial of defibrotide for the treatment of severe VOD in the United States, Canada, and Israel; and a Phase II/III pediatric trial in Europe for the prevention of VOD. It also offers sulglicotide that is developed from swine duodenum, and has ulcer healing and gastrointestinal protective properties in South Korea; and urokinase, which is made from human urine to treat various vascular disorders, such as deep vein thrombosis and pulmonary embolisms. The company was formerly known as Pharma Research S.r.L. and changed its name to Gentium S.p.A. in July 2001. Gentium S.p.A. was founded in 1993 and is headquartered in Villa Guardia, Italy.

Advisors' Opinion:
  • [By Sean Williams]

    A parabolic problem
    It has also been a year to remember for shareholders of biopharmaceutical company Gentium (NASDAQ: GENT  ) whose share price has catapulted approximately 600% off its lows thanks to growth in its lead drug Defibrotide (known as Defitelio in the European Union).

  • [By James Oberweis]

    Gentium Spa (GENT) is focused on the development and commercialization of its leading product, defibrotide, to treat certain complications arising from chemotherapy, and bone marrow and stem cell transplantation therapy.

  • [By Jake L'Ecuyer]

    Shares of Jazz Pharmaceuticals Public Limited Company (NASDAQ: JAZZ) got a boost, shooting up 7.77 percent to $123.65 after the company announced its plans to buy Gentium SpA (NASDAQ: GENT) for around $1 billion.

Top 10 Biotech Stocks To Buy Right Now: Imprimis Pharmaceuticals Inc (IMMY)

Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company�� Transdel cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel, the Company�� lead pain product, utilizes the Transdel platform technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the skin directly into the underlying tissues where the drug exerts its anti-inflammatory and analgesic effects. Ketotransdel consists of a transdermal formulation of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), and its Transdel drug delivery system and is being developed for the treatment of acute pain. In July 2013, it acquired intellectual property for IPI-120 from Buderer Drug Company.

Ketotransdel penetrates the skin barrier to reach the targeted underlying tissues where it exerts its localized anti-inflammatory and analgesic effect. Transdel is the Company�� transdermal cream drug delivery platform. It consists of a cream that enables transdermal penetration of drugs avoiding first pass metabolism by the liver and minimizing systemic exposure. The Transdel drug delivery system facilitates the effective dissolution and delivery of a drug across the skin barrier to reach targeted underlying tissues.

Advisors' Opinion:
  • [By John Udovich]

    So far this year, Rexahn Pharmaceuticals, Inc (NYSEMKT: RNN), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and Arrowhead Research Corp (NASDAQ: ARWR) are up 186.3%, 157.2% and 142.5%, respectively, since the start of the year���making them the best performing small cap biotech stocks for 2014. But given their lackluster performance over the past few years, what is the secret behind their phenomenal 2014 rise and will they keep rising? For starters, none of these small caps have really produced anything in the way of blockbuster news:

  • [By John Udovich]

    The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:

Top 10 Biotech Stocks To Buy Right Now: NanoViricides Inc (NNVC)

NanoViricides, Inc., incorporated on April 1, 2005, is a development-stage company. The Company is a nano-biopharmaceutical (nanomedicine) company whose business goals are to discover, develop and commercialize therapeutics to advance the care of patients suffering from life-threatening viral infections. The Company has several drugs in various stages of early development. The Company�� drugs are based on several patents, patent applications, provisional patent applications, and other property held by TheraCour Pharma, Inc. (TheraCou), to which the Company has exclusive licenses in perpetuity for the treatment of human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Influenza including Asian Bird Flu Virus (INF), Herpes Simplex Virus (HSV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV), and Rabies. As of June 30, 2012, the Company had six drug development programs: Oral FluCideTM, against all Influenzas; a Piggy-back version of Flucide for hospitalized patients; nanoviricide eye drops against adenoviral EKC and herpes keratitis; HIVCide - I against HIV/AIDS; HerpeCide - I skin cream formulation for herpes cold sores and genital warts, and DengueCide, a broad spectrum nanoviricide designed to attack all types of dengue viruses and expected to be effective in the Severe Dengue Disease syndromes including Dengue Hemorrhagic Fever (DHS) and Dengue Shock Syndrome (DSS). As of June 30, 2012, it had engaged in organizational activities, sourcing compounds and materials, developing novel compounds and nanomaterials, and experimentation with studies on cell cultures and animals. In September 2011, NanoViricides Inc's Inno-Haven LLC acquired a light industrial building.

The Company's product development programs are divided into three sectors: commercially important diseases, neglected tropical diseases (NTD��) and biosecurity/biodefense, and advanced technologies. The Company has collaborations with KARD Scientific, Inc., MA. and Southern Research Institute, AL for influenza viruse! s; National (Central) Institute of Hygiene and Epidemiology (NIHE) (Vietnam), for H5N1 avian flu; The Long Island Jewish Medical System, Feinstein Institute of Medical Research (LIJMS), NY and TheVac, LLC. for viral diseases of the eye (adenoviruses, herpesviruses - epidemic kerato-conjunctivitis (EKC), Herpes Keratitis); TheVac, LLC and Northeastern Ohio Medical University (NEOMED) for herpes virus infections; University of California at Berkeley for dengue hemorrhagic fever viruses; Center for Disease Control and Prevention (CDC) and National (Central) Institute of Hygiene and Epidemiology for rabies virus. The Company has developed lead drug candidates against a number of viral diseases.

The Company had consolidated all of its influenza drug programs into a single pan-influenza FluCide program. It is developing a single drug for all influenzas, whether pandemic, epidemic, seasonal, novel, emerging, human, swine, or avian. It is developing a nanoviricide against adenoviral EKC. The nanoviricide eye drug candidate is formulated as simple eye drops. It is developing an anti-HSV nanoviricide skin cream formulation for direct application to the lesions. It has designed the anti-HIV nanoviricides using rational drug design principles. The ligands it has designed in the case of HIV-1 are thought to be broadly neutralizing. In-silico modeling indicates that its ligands dock to the conserved CD4 binding site of gp120 of HIV-1. The Company is working on developing anti-Dengue therapeutics. Dengue is an important NTD. Its RabiCide program has resulted in candidates that have enabled survival of 20% to 30% of infected animals after disease has set in, using a particular animal model.

The Company competes with Roche, Glaxo SmithKline, BioCryst Pharmaceuticals, Inc., Gilead, Bristol-Myers Squibb Company (BMS), Roche, Boehringer Ingelheim, Merck & Co., Inc. (Merck), Valeant, Schering, Pharmassett, Vertex, Intermune, Achillion and Novartis.

Advisors' Opinion:
  • [By Roberto Pedone]

    One under-$10 nano-biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Nanoviricides (NNVC), which engages in the discovery, development and commercialization of anti-viral therapeutics primarily in the U.S. This stock has been ripping to the upside so far in 2013, with share up big by 198%.

    If you take a look at the chart for Nanoviricides, you'll notice that this stock has recently formed a double bottom chart pattern at $4.55 to $4.52 a share. Following that bottom, shares of NNVC have now started to uptrend and move within range of triggering a big breakout trade. That trade will hit if NNVC manages to take out the upper-end of its recent sideways trading chart pattern, which has seen NNVC trend between $4.55 and $5.74 a share.

    Traders should now look for long-biased trades in NNVC if it manages to break out above some near-term overhead resistance levels at Friday's high of $4.94 a share to its 50-day moving average of $5.28 a share, and then once it takes out some more key overhead resistance levels at $5.72 to $5.74 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 234,994 shares. If that breakout triggers soon, then NNVC will set up to re-test or possibly take out its next major overhead resistance levels at $6.50 to its 52-week high at $7.59 a share.

    Traders can look to buy NNVC off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $4.55 to $4.52 a share. One can also buy NNVC off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Biotech Stocks To Buy Right Now: Johnson & Johnson(JNJ)

Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment provides products used in baby care, skin care, oral care, wound care, and women?s health care fields, as well as nutritional, over-the-counter pharmaceutical products, and wellness and prevention platforms under the brands of JOHNSON?S, AVEENO, CLEAN & CLEAR, JOHNSON?S Adult, NEUTROGENA, RoC, LUBRIDERM, DABAO, LISTERINE, REACH, BAND-AID, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC. The Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, and virology. Its principal products include REMICADE for the treatment of immune me diated inflammatory diseases; STELARA for the treatment of moderate to severe plaque psoriasis; SIMPONI, a treatment for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis; VELCADE for the treatment of multiple myeloma; PREZISTA and INTELENCE for treating HIV/AIDS patients; NUCYNTA for moderate to severe acute pain; INVEGA SUSTENNAtm for the acute and maintenance treatment of schizophrenia in adults; RISPERDAL CONSTA for the management of bipolar I disorder and schizophrenia; and PROCRIT to stimulate red blood cell production. The Medical Devices and Diagnostics segment primarily offers circulatory disease management products; orthopaedic joint reconstruction, spinal care, and sports medicine products; surgical care, aesthetics, and women?s health products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. The company was founded in 1886 and is based in Ne w Brunswick, New Jersey.

Advisors' Opinion:
  • [By Matt Thalman]

    Johnson & Johnson (NYSE: JNJ  ) also delivered quarterly results, beating estimates on both the top and bottom lines -- yet shares are nonetheless flat this afternoon. Johnson posted ex-item earnings of $1.48 per share on revenue of $17.88, topping expectations of $1.39 in EPS and $17.72 billion in revenue. But despite beating the Street, the management team did note a number of times during the conference call that the company is experiencing pricing pressure from the government and insurance payers. Additionally, the company cited changes in the "dynamic global macroeconomic environment" as a reason to be concerned about revenue growth.�

Top 10 Biotech Stocks To Buy Right Now: ImmunoCellular Therapeutics Ltd (IMUC)

ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient�� own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies. The Company�� products include ICT-107, ICT-140, ICT-120, ICT-109 and DIAAD. ICT-107, the pipeline product, is a Phase II therapeutic dendritic cell (DC) vaccine for the treatment of glioblastoma multiforme (GBM), the common and lethal type of brain cancer. ICT-107 is designed to activate a patient�� immune system to target six different tumor-associated antigens. In February 2012, it acquired a world-wide license from the University of Pennsylvania and The John Hopkins University (JHU).

The Company in addition to ICT-107, is also developing other therapeutic DC vaccines: ICT-140 for ovarian cancer and ICT-121 for recurrent GBM. ICT-140 targets seven tumor-associated antigens expressed on ovarian cancer cells. ICT-107 is a DC vaccine that targets six different tumor-associated antigens that are found on patients��tumor cells; four of the six antigens are expressed on CSCs. The therapeutic vaccine is used subsequent to conventional therapy or concomitantly with chemotherapy in patients with newly diagnosed GBM. ICT-140 is a DC vaccine that targets seven different ovarian cancer antigens. ICT-121 is a DC vaccine that targets CD133 antigens; it has the potential to be a universal cancer vaccine because CD133 is widely expressed on CSCs from a majority of cancers. Data from this small study demonstrated that ICT-109 had a statistically ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets. The DIAAD (differential immunization for an! tigen and antibody discovery) platform it acquired from Molecular Discoveries utilizes immunological tolerization to accelerate the discovery of the molecular differences between diseased cells and their normal counterparts. The monoclonal antibodies produced by DIAAD provide the basis for the discovery and development of its potential diagnostic and therapeutic products.

The Company competes with Dendreon, Oncothyreon, Galena, Bavarian Nordic and Immunovaccine, Northwest Biotherapeutics, Prima Biomed, DCPrime, Roche/Genentech, Seattle Genetics, Bristol-Myers Squibb and Immunogen.

Advisors' Opinion:
  • [By Wallace Witkowski]

    Shares of ImmunoCellular (IMUC) �jumped after the drug developer said data on a mid-stage brain cancer drug study were looking encouraging.

Top 10 Biotech Stocks To Buy Right Now: Receptos Inc (RCPT)

Receptos, Inc. (Receptos), incorporated on June 9, 2008, is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapeutics for immune disorders. The Company�� product candidates span three specialty disease areas. The Company�� lead asset, RPC1063, is being developed as an oral therapy for the treatment of relapsing multiple sclerosis (RMS) and inflammatory bowel disease (IBD). Its second asset, RPC4046, is being developed for the treatment of an allergic/immune-mediated disorder, eosinophilic esophagitis (EoE), which is an orphan disease. RPC1063 is an oral, once daily, selective and potent sphingosine 1-phosphate 1 receptor (S1P1R) modulator. RPC4046 is a monoclonal antibody selective to interleukin-13 (IL-13) and produced by recombinant deoxyribonucleic acid (DNA) technology.

As of December 31, 2012, RPC1063 was being tested in the Phase II portion of an accelerated design, randomized Phase II/III study for the treatment of RMS. In addition, Receptos has obtained special protocol assessment (SPA) agreement from the United States food and drug administration (FDA) on its clinical trial design for the planned Phase III portion of the Phase II/III study, as well as a second planned RMS Phase III study. RPC1063 is also being tested in a randomized Phase II study for the treatment of ulcerative colitis (UC), a gastrointestinal (GI) disea se.

As of December 31, 2012, the Company was enrolling a randomized Phase II study evaluating the ability of RPC1063 to induce clinical remission in patients with moderately-to-severely active UC called TOUCHSTONE. The Company�� second asset, RPC4046 for the treatment of EoE, builds upon its competencies in immunology and GI diseases. In-licensed from AbbVie Bahamas Ltd. and AbbVie Inc. (AbbVie) RPC4046 is a monoclonal antibody directed against the IL-13 target, which has been validated in Asthma, a predominantly allergic/immune-mediated disorder.

Advisors' Opinion:
  • [By John Udovich]

    Small cap �biopharmaceutical stock Receptos Inc (NASDAQ: RCPT) was one of the many hot biotech IPOs of last year and its also up 72.4% since the start of this year alone, meaning its time to take a closer look at this small cap stock with potential treatments for Relapsing Multiple Sclerosis (RMS) and Inflammatory Bowel Disease (IBD) along with the performance of biotech ETF benchmarks like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).

  • [By Roberto Pedone]

    Receptos (RCPT) is a biopharmaceutical company engaged in discovering, developing and commercializing therapeutics for immune disorders. This stock closed up 5% at $23.19 in Monday's trading session.

    Monday's Volume: 69,000

    Three-Month Average Volume: 55,356

    Volume % Change: 50%

    From a technical perspective, RCPT ripped higher here right above some key near-term support at $21 with decent upside volume. This move is quickly pushing shares of RCPT within range of triggering a major breakout trade. That trade will hit if RCPT manages to take out its all-time high at $25 with high volume.

    Traders should now look for long-biased trades in RCPT as long as it's trending above support at $21 and then once it sustains a move or close above its all-time high at $25 with volume that's near or above 55,356 shares. If that breakout hits soon, then RCPT will set up to enter new all-time-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $30 to $35.

  • [By RichardCox]

    For those willing to take on some added volatility (and potential for increased risk based on less diversification), investors can look at Receptos Inc. (RCPT), to play this year's momentum in IPO entries. Enhanced expectations for the company's IPO drove the company to raise its initial share offering to 5.2 million shares. Receptos has reached late-stage development for its oral treatment for multiple sclerosis (MS). MS treatments are dominated by industry heavyweights but MS pills are expected to surge in the next few years because oral treatments are becoming more efficient than injected therapies, and can cater to a broader consumer base. Being a new company, the Receptos chart only offers limited incite, and will not be included here.

Top 10 Biotech Stocks To Buy Right Now: Evolva Holding SA (EVE)

Evolva Holding SA (Evolva) discovers and provides ingredients for health, nutrition and wellness. Evolva uses biosynthetic and evolutionary technologies to create small molecule compounds and their production routes. The Company�� nutrition and consumer products include Pomecins, saffron, stevia, vanilla and resveratrol. The Company�� pharmaceuticals products include EV-077 and EV-035. In pharmaceuticals, the Company focuses on oral, small molecule drugs with application in complications of diabetes and infectious diseases. Pomecins are Evolva�� compounds. Evolva is focused on two members of the family - Pomecin A and Pomecin B. EV-035 is a bacterial type II topoisomerase inhibitor. Evolva is developing EV-077 for the treatment of diabetic complications. It is an oral, small molecule compound, belonging to a structural class. Advisors' Opinion:
  • [By Glenwoods]

    Earlier this year the giant food processor, Cargill, partnered with the small Swiss company, Evolva (SIX:EVE), which was developing its own stevia-based fermentation process, also in the pilot stage. As noted earlier in the article, Cargill is in a partnership with Coca-Cola for Truvia, the bestselling stevia product on the market. The success of the Cargill/Evolva partnership could have big implications not just for Cargill and Coca-Cola, but also on the entire stevia and sweetener market. I further believe the success of the partnership could have a major impact on Stevia First. If Cargill�� fermentation method produces a better tasting stevia product at a lower cost it would give Coca-Cola a considerable advantage over the other beverage bottlers, food manufacturers, and stevia producers. Such an outcome would force these companies to scramble to find a similar method in order to compete. There would be a very good chance that rival companies, in order to stay in the game, would have to turn to the other company developing a fermentation-based stevia product-- Stevia First. If that happens Stevia First�� value would rise considerably.

Best Integrated Utility Stocks For 2014

Container Store Group Inc. (NYSE:TCS) will release its financial results for the first quarter of fiscal 2014 after market close on Tuesday, July 8, 2014. The company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results.

Wall Street anticipates that the Specialty Retailer will lose $0.06 per share for the quarter. iStock expects TCS to top Wall Street's consensus number, the iEstimate is -$0.05. Container Store's consensus revenue estimate for Q1 is $ 174.21 million.

The Container Store Group, Inc. is engaged in the retailing of storage and organization products in the United States. It operates in two segments, TCS and Elfa. The company's retail stores provide various lifestyle products, including bath, box, closets, collections, containers, food storage, gift packaging, hooks, kitchen, office, shelving, storage, trash, and travel, as well as its Elfa products. As of March 1, 2014, it operated 63 stores with an average size of approximately 19,000 selling square feet in 22 states and the District of Columbia.

10 Best Healthcare Technology Stocks To Invest In Right Now: Medical Marijuana Inc (MJNA)

Medical Marijuana Inc. (MJNA), incorporated on May 23, 2005, is the publicly held company vested in the medical marijuana and industrial hemp markets. The Company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. These products range from patented based cannabinoid products, to whole plant or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries. In March 2013, it sold certain equipment and inventory, web domain names, phone numbers, and all existing and pending agreements with hemp production and processing facilities to CannaVEST Corp.

The Company�� services are varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 50 and patented cannabinoid delivery methods that are more socially and medically acceptable than smoking.

Advisors' Opinion:
  • [By James E. Brumley]

    Wow. That didn't take long. It was only two days ago that marijuana stocks like Growlife Inc. (OTCBB:PHOT), Medical Marijuana Inc. (OTCMKTS:MJNA), Cannabis Science Inc. (OTCMKTS:CBIS), Medbox Inc. (OTCMKTS:MDBX), and Hemp, Inc. (OTCMKTS:HEMP) were all the rage, flying high on the heels of a new year... a new year in which marijuana was legalized (for one reason or another) in two more states. HEMP was up as much as 700% in less than three weeks at one point. MDBX gained 300% at the beginning of the year, when recreational marijuana began to be legally sold in Colorado. CBIS jumped 400% off of its December low. MJNA nearly doubled on the advent of new marijuana venues. PHOT soared more than 130% since the end of last year on the legalization of marijuana. It was, truthfully, some of the fastest big money that traders have ever made in the market.

  • [By Dan Burrows]

    Medical Marijuana Inc. (MJNA) is up just under 100% so far this year and — get this — MJNA stock is actually the big-time laggard in the group. Next up comes Growlife (PHOT), as PHOT stock has gained “only” 150%. Indeed, when it comes to medical marijuana stock, anything less than a three-fold gain is small beer.

  • [By James E. Brumley]

    If it seems like the buzz surrounding marijuana stocks like Medical Marijuana Inc. (OTCMKTS:MJNA), Hemp, Inc. (OTCMKTS:HEMP), and GreenGro Technologies, Inc. (OTCMKTS:GRNH) has been a little louder than usual the last few days, you're not crazy - it has been louder, and particularly bullish. GRNH shares advanced 37% in December. HEMP is up 166% for the past two weeks. MJNA has jumped 47% in just the past couple of days. Well, as it turns out, it's not just mere coincidence that GreenGro Technologies, Hemp, Medical Marijuana, and a bunch of other cannabis-related names have perked up of late. And, odds are pretty good they'll all continue to do well (even of the pace slows a bit) in 2014.

Best Integrated Utility Stocks For 2014: InterDigital Inc.(IDCC)

Interdigital, Inc. engages in the design and development of digital wireless technology solutions. The company offers technology solutions for use in digital cellular and wireless products and networks, including 2G, 3G, 4G, and IEEE 802-related products and networks. It holds patents related to the fundamental technologies that enable wireless communications. The company licenses its patents to equipment producers that manufacture, use, and sell digital cellular and IEEE 802-related products; and licenses or sells mobile broadband modem solutions, including modem IP, know-how, and reference platforms to mobile device manufacturers, semiconductor companies, and other equipment producers that manufacture, use, and sell digital cellular products. InterDigital?s solutions are incorporated in various products comprising mobile devices, such as cellular phones, tablets, notebook computers, and wireless personal digital assistants; wireless infrastructure equipment, such as base stations; and components, dongles, and modules for wireless devices. The company was founded in 1972 and is headquartered in King of Prussia, Pennsylvania.

Advisors' Opinion:
  • [By Lisa Levin]

    InterDigital (NASDAQ: IDCC) shares climbed 5.45% to $30.29. The volume of InterDigital shares traded was 195% higher than normal. InterDigital and Huawei reached a settlement pact.

Best Integrated Utility Stocks For 2014: Internet Gold Golden Lines Ltd (IGG)

Internet Gold Golden Lines Ltd., incorporated in April 1992, is a communications services provider. The Company�� subsidiaries are B Communications Ltd. (B Communications) (formerly 012 Smile.Communications Ltd.) and GoldMind Ltd. (formerly Smile.Media Ltd.). B Communications is the controlling shareholder of Bezeq. It owns 78.11% of the interest B Communications. Bezeq is the principal provider of communications services in Israel. The Group has four areas of operation, which include Bezeq domestic fixed-line communications, Pelephone Communications Ltd., Bezeq International Ltd. and D.B.S. Satellite Services (1998) Ltd. The Company�� subsidiary, B Communications, holds 30.44% interest of Bezeq (TASE:BZEQ). On March 14, 2011, B Communications purchased additional interest in Bezeq increasing its ownership interest to 31.37%. On March 3, 2011, Partner completed its acquisition of 012 Smile.

Bezeq domestic fixed-line communications primarily includes Bezeq�� operation as a domestic operator, including telephony services, Internet services, transmission services and data communications. Pelephone Communications Ltd. provides cellular services (cellular communications), marketing of end-user equipment, installation, operation and maintenance of cellular communications equipment and systems. Bezeq International Ltd. provides international communications services, Internet access (ISP) services, and network endpoint (NEP) services. D.B.S. Satellite Services (1998) Ltd. provides multi-channel broadcast and value added services via satellite.

Bezeq fixed-line business

Bezeq's telephony services include basic telephony services on domestic telephone lines and associated services, such as voice mail, caller identity (ID), call waiting, call forwarding, speed dial, and conference calls. Bezeq also provides national services for businesses (1-800, 1-700) that offer full or partial payment for incoming calls by businesses. As of December 31, 2010, Bezeq operated about ! 12,500 public telephones around the country, which were operated by various types of pre-paid cards. Bezeq operates a unified telephone directory for fixed-line and cellular telephony operators, as well as a unified Website, which is free of charge, in addition to its 144 (directory information) service. As of December 31, 2011, Bezeq had 2,367,000 active telephone lines.

Bezeq provides broadband Internet access infrastructure services in xDSL technology. As of December 31, 2011, Bezeq had 1,111,000 Internet subscribers. Data communications services are network services for point-to-point transfer of data, transfer of data between computers and various communications networks, services to connect communications networks to the Internet, and remote access services. The companies operating in this field are Cellcom, Partner (which acquired the Med-1 operation), HOT and Internet companies that also use leased infrastructures. Bezeq offers transmission services, including high speed services, to other communications operators and to its business customers over a variety of protocols. At December 31, 2011, the percentage of Internet subscribers connected to the next generation network (NGN) was approximately 87% of Bezeq's total Internet subscribers, and the percentage of subscribers using NGN services was 48% of all Internet subscribers connected to the NGN network.

Bezeq provides services to other communications operators, including the cellular and international operators, cable broadcasting license-holders, NEP operators, ISPs, domestic operators, and Palestinian communications providers. Bezeq�� services include infrastructure, connection to Bezeq's network, transmission, billing and collection, rental of space and provision of services in its rented properties and rights of use for seabed cables. Bezeq operates and maintains radio transmitters, including those operated by the Israel Broadcasting Authority, television transmitters of Channel 1, Educational Television and Cha! nnel 2, a! nd the transmitters of regional radio stations. Bezeq also operates digital terrestrial television (DTT) transmitters. Bezeq is responsible only for operation and maintenance of the transmitters for distribution of radio and television programs, and not for the content of the broadcasts.

Bezeq performs setup and operation work on networks and sub-networks for various customers, such as the Ministry of Defense, HOT, radio and television broadcasting companies, cellular and international communication operators, local authorities, municipalities and government agencies. Bezeq and HOT have agreements for the provision of installation and maintenance services of cable networks, on Bezeq's infrastructure, from the starting point of those licensees��operating center, up to the point of delivery at the entrance to subscribers��homes. The IP Centrex service is a virtual private exchange service. Data Center service enables provision of a solution for customers from the aspects of backup and survivability. 144 Internet site is a search engine for finding business and private telephone numbers. Bezeq�� launch of its new generation network (NGN) has enabled it to offer new services, such as Bphone (a service enabling telephone calls to be made through the Internet as calls made from a fixed-line phone), on-hold music, storage services on the network and home exchange services.


Pelephone provides its subscribers with an offering of voice transmission, transmission of text messages, data communications and advanced multimedia services. Pelephone�� service package includes basic call services, call completion services and auxiliary services, such as call waiting, call forwarding, voice mail, voice conference call and caller ID. Pelephone offers its customers value added services, such as Internet surfing, text messaging and information services using short message service SMS (text), multimedia messaging service (MMS) messages, voice information services using ! special p! urpose asterisks, information and entertainment services through as Internet portal. Pelephone�� value added services also include the ability to watch various television channels, such as music, sports, news and entertainment channels, and the ability to photograph and forward video files.

Pelephone provides roaming services (communications by means of cellular handsets from different locations around the world) in accordance with agreements it has with cellular operators abroad, enabling Pelephone to access their networks. Pelephone offers its customers a repair service for a monthly payment entitling the customer to a warranty for the cellular handset, or for a one-time payment at the time of repair. Pelephone offers its customers various types and brands of cellular telephones, on-board telephones and hands-free devices, as well as support for its range of services. Pelephone also supplies its customers with modems and laptop computers for surfing the Internet through the Pelephone network. Pelephone provides roaming services (communications by means of cellular handsets from different locations around the world) in accordance with agreements it has with cellular operators abroad, enabling Pelephone to access their networks. The roaming tariffs are defined in the Individual Annex. Pelephone offers its customers a repair service for a monthly payment entitling the customer to a warranty for the cellular handset, or for a one-time payment at the time of repair. Pelephone offers its customers various types and brands of cellular telephones, on-board telephones and hands-free devices, as well as support for its range of services. Pelephone also supplies its customers with modems and laptop computers for surfing the Internet through the Pelephone network.

Bezeq International

Bezeq International provides communication solutions to its customers in the private and business sectors, in four areas of operation. It includes Internet access services, International tele! phony ser! vices, NEP services, and Data and Information and Communication Technology (ICT), solutions. In the voice services sector, Bezeq International provides international direct dialing (IDD), services to business and private customers; toll-free number services for business customers overseas; international call routing and termination services (hubbing) transfer of international calls between foreign communication providers (worldwide), calling card services enabling prepaid and postpaid dialing from and to Israel, for business and private customers, and the 1809 service for dialing from Israel to other countries. Bezeq International also provides domestic telephony services by means of Voice over Broadband (VOB), access.

In the Internet services sector, Bezeq International provides Internet access services for private and business customers, including terminal equipment and support, with an emphasis on broadband Internet based on asymmetric digital subscriber line (ADSL) or cable infrastructures; hosting services site storage and server services in a designated installation for business and private customers, including value-added services (such as monitoring and control); information security services, services securing customers Internet and local area network (LAN) connections using the required terminal equipment or software, including monitoring; data services with international data communication IP solutions for business customers, including global deployment if necessary, and wireless fidelity (WIFI) access fast wireless access solutions for private and business customers, including in various public locations (hotspots).

Bezeq International supplies of international data communication solutions for business customers, including customized global deployment. As part of the service contracts, Bezeq International supplies direct maintenance of a range of exchange manufacturers. The services are given to gateways, exchanges and NEP designated for use with both internal and ! external ! lines. As part of business information technology (IT) solutions, Bezeq International provides communications services, including data and overseas communication services, server and Website hosting services, technical maintenance and support services, networking and system services, outsourcing and out-tasking services, security and risk management solutions and IP based services. Bezeq also provides ICT solutions to business customers as part of an overall ICT solution for businesses. Bezeq International provides broad communications services, including international data and communication services, server and site hosting services, technical support and maintenance services, network and system services, outsourcing and out-tasking services, security and risk management solutions and managed IP services.


DBS�� broadcasts approximately 150 different video channels, of which 14 are pay-per-view (PPV) channels and 19 are high definition (HD), channels, 20 radio channels, 30 music channels and interactive services. The broadcasts include a basic package which each subscriber is required to purchase as well as additional channels chosen by the subscriber, whether as a package or as single and PPV channels. The main channel packages marketed by DBS in addition to the basic package are the movie, entertainment, children's, music, sports, science and nature packages. DBS also has a content Website which is operated together with Walla! which allows viewing of various forms of content, some of them at a fee. DBS markets personal video recorder (PVR), decoders which interface with DBS�� electronic broadcast schedule and enable receipt of special services, including ordering recordings in advance, recording series and pausing live broadcasts. DBS also provides its subscribers with HD broadcasts, which can be received through special decoders.

The Company competes with Cellcom Israel Ltd., or Cellcom, Partner. 013 Netvision, 012 Smile, 018 Xfone, HILAT Israel Telecom! municatio! ns Company Ltd., and Telzar International Communication Services Ltd.

Advisors' Opinion:
  • [By Alexis Xydias]

    Brokerages are beating banks and the broader market in Europe. The Stoxx 600 Financial Services Index has gained 12 percent this year, more than twice the 5.6 percent advance for a gauge of European banks. Hargreaves Lansdown Plc (HL/), the U.K.�� largest retail broker, which received record cash in its latest quarter, according to an April 17 statement, advanced 33 percent. IG Group Holdings Plc (IGG), the London-based provider of spread betting, rose 30 percent.

Best Integrated Utility Stocks For 2014: MeetMe Inc (MEET)

MeetMe, Inc. (MeetMe), incorporated on April 17, 2011, is a social network for meeting new people in the United States and the public market for social discovery. MeetMe makes meeting new people fun through social games and apps, monetized by both advertising and virtual currency. The Company has 60% customers coming from mobile. MeetMe is the social gathering place for the mobile generation. The Company operates and MeetMe apps on iPhone, iPad, and android in English, Spanish and Portuguese.

The Company provides advertising facilities through MeetMe Ads and Social Theater. MeetMe Ads had over two billion page views monthly, over 78 million registered users across the world and approximately 50% of activity on mobile, as of November 17, 2012. Social Theater consists of traditional marketing and social networking.

Advisors' Opinion:
  • [By Rich Bieglmeier]

    Harper say of his new idea, "We are initiating coverage of social networking platform MeetMe, Inc. (MEET) with a Buy rating and a $4.50 price target. We expect the company to increase the number of mobile active users, their monetization levels, and its FY15 revenues above the consensus through enhancements to its core app, its mobile advertising deals, and broader trends with younger people sharing content via mobile apps."

  • [By James E. Brumley]

    A week and a half ago I was singing the bullish praises of MeetMe Inc. (NYSEMKT:MEET). Not only was I impressed by the way shares of MEET had wrestled their way from underneath some serious technical resistance, I was sure that modest nudge was the beginning of several more breakthroughs that would propel the stock to much higher highs and reward faithful investors who stepped in on my advice.

  • [By James E. Brumley]

    It's not been easy to be a fan of MeetMe Inc. (NYSEMKT:MEET) since July of last year. In fact, sometimes it's been downright painful to keep holding MEET. But, it was also worth it. With today's big move, MeetMe shares have cleared a key hurdle, and they've done so for all the right reasons. Investors who've been cautiously waiting on the sidelines may want start wading in now.

Best Integrated Utility Stocks For 2014: TotalFinaElf S.A.(TOT)

TOTAL S.A., together with its subsidiaries, operates as an integrated oil and gas company worldwide. The company operates through three segments: Upstream, Downstream, and Chemicals. The Upstream segment engages in the exploration, development, and production of oil and natural gas. It also involves in the transportation, trade, and marketing of natural gas and liquefied natural gas (LNG), as well as in LNG re-gasification and natural gas storage operations. In addition, this segment engages in the shipping and trade of liquefied petroleum gas (LPG); power generation from gas-fired power plants, nuclear, or renewable energies; production, trade, and marketing of coal, as well as in solar power systems and technology operations. As of December 31, 2010, it had combined proved reserves of 10,695 Mboe of oil and gas. The Downstream segment involves in refining, marketing, trading, and shipping crude oil and petroleum products. It also produces a range of specialty products, s uch as lubricants, LPG, jet fuel, special fluids, bitumen, marine fuels, and petrochemical feedstock. This segment holds interests in 24 refineries located in Europe, the United States, the French West Indies, Africa, and China, as well as operates a network of 17,490 service stations. The Chemicals segment produces base chemicals, including petrochemicals and fertilizers, as well as engages in rubber processing, resins, adhesives, and electroplating activities. TOTAL S.A. was founded in 1924 and is based in Paris, France.

Advisors' Opinion:
  • [By Tyler Crowe]

    At the same time, this is what makes Cheniere Energy such a difficult investment in 2014, it is still not generating any revenue from these ventures yet. Sure, the company receives some contract royalties from Total (NYSE: TOT  ) and Chevron (NYSE: CVX  ) from when its facilities were geared for LNG import, but in no way do they cover the capital expenditures necessary to get these facilities up and running.�

  • [By Dan Carroll]

    Europe has also experienced a tough economic climate this year, and the German DAX (DAXINDICES: ^DAX  ) and French CAC 40 indexes haven't had the best time so far in 2013. France's index has managed to climb a fraction of a percent, but that hasn't helped many French stocks this year: French oil giant Total SA (NYSE: TOT  ) has lost more than 10% year to date despite the company's forward-looking moves to expand into Africa and other locations; Total recently agreed to the construction of a refinery in Uganda for 30,000 barrels per day of refining. The DAX has dipped as Germany, long one of the lone bright spots in Europe, has seen its economy suffer from the eurozone's crisis and its PMI dive into contraction territory.

  • [By Varun Chandan, Arora]

    The Yamal LNG project, which is being developed by Novatek, France's Total SA (NYSE: TOT  ) , and China's CNPC, already has the required permits. The LNG plant will have three trains with total capacity of 16.5 million tons of LNG per year, with the first LNG train currently scheduled to start-up in late 2017. The main market for LNG will be China.

Thursday, August 28, 2014

Top 5 Quality Stocks To Invest In 2014

Lululemon (NASDAQ: LULU  ) made a name for itself in the athletic-apparel industry by offering top-of-the-line yoga wear made with technical fabrics, such as luon and silverescent. "Quality is at the heart of everything we do, from the technical features we (sometimes literally) weave into our products, to the people we work with and relationships we build," or so Lululemon boasts on the�company website.

Unfortunately, Lulu's reputation for quality has been stretched a bit thin lately. As you probably know, the company was forced to pull more than 17% of its signature luon pants from store shelves following an issue with sheerness. In fact, the see-through pants recall could end up costing Lulu as much as $67 million in lost revenue this year.

When the problem first surfaced last month, Lululemon was quick to blame its longtime Taiwanese supplier Eclat Textile. Now, after a back and forth game of "we said, they said," it seems Lululemon is finally ready to take some responsibility for the recent quality control issues.

Best Asian Stocks To Invest In 2015: American Apparel Inc (APP)

American Apparel, Inc. incorporated on July 22, 2005, is a vertically integrated manufacturer, distributor, and retailer of branded fashions basic apparel and accessories for women, men, children and babies. As of January 31, 2013, the Company had operated 251 retail stores in 20 countries. The Company also operates an e-commerce site that serves over 60 countries worldwide at . In addition, American Apparel operates a business that supplies T-shirts and other casual wear to distributors and the imprintable industry. The Company operates in four business segment: U.S. Wholesale, U.S. Retail, Canada, and International.

The U.S. Wholesale segment consists of the Company's wholesale operations of sales of undecorated apparel products to distributors and third party screen printers in the United States, as well as its online consumer sales to United States customers. The U.S. Retail segment consists of the Company's retail store operations in the United States. The Canada segment consists of the Company's retail, wholesale and online consumer operations in Canada. As of December 31, 2012 , the retail operations in the Canada segment consisted of 35 retail stores. The International segment consists of the Company's retail, wholesale and online consumer operations outside of the United States, and Canada. As of December 31, 2012 , the retail operations in the International segment were consisted of 76 retail stores.

As of December 31, 2012 , the Company's retail operations consisted of 251 retail stores in 20 countries, including the United States, Canada, Mexico, Brazil, United Kingdom, Ireland, Austria, Belgium, Germany, France, Italy, the Netherlands, Spain, Sweden, Switzerland, Israel, Australia, Japan, South Korea and China. The Company's wholesale operations sell to over a dozen authorized distributors and approximately 10,000 screen printers and advertising specialty companies. The Company operates 12 online stores in the United States, Canada, the U! nited Kingdom, Continental Europe, Switzerland, Japan, South Korea, Australia, Mexico, Brazil, Singapore and Hong Kong.

The Company competes with The Gap, Urban Outfitters, H&M, Uniqlo, Forever 21, Gildan Activewear, HanesBrands, Russell Athletic and Fruit of the Loom.

Advisors' Opinion:
  • [By Michael Hamlett Jr]

    American Apparel (APP) is an American clothing manufacturer, distributor and retailer. APP suspended its CEO, Dov Charney, but has kept him as a consultant pending further investigation into his conduct. To say that APP is struggling would be a huge understatement. If New York investment firm Standard General didn't acquire Charney's 44% stake in the company for $25 million and pay for a $10 million loan at 20% interest from Lion Capital, the company would probably be filing for brankruptcy.

  • [By James E. Brumley]

    Two weeks ago, yours truly penned some bullish thoughts on American Apparel Inc. (NYSEMKT:APP). Although the stock was in an "almost" situation at the time, APP shrugged off the "almost" condition the very next day and confirmed its bullishness. It's possible even that bullish feat wasn't convincing, but after yesterday' and today's action, it's going to be impossible to decide American Apparel still isn't over the hump.

Top 5 Quality Stocks To Invest In 2014: Sparton Corporation(SPA)

Sparton Corporation, together with its subsidiaries, offers electronic manufacturing services primarily for medical device, defense and security systems, and electronic manufacturing services industries worldwide. The company?s Medical segment engages in the contract development, design, production, and distribution of medical related electromechanical devices for the medical OEM and ET customers primarily in the vitro diagnostic and therapeutic device areas. Its EMS segment involves in the contract manufacturing, assembly, design, preproduction, prototyping, and/or box building assemblies, such as flight control systems and fuel control systems for the aerospace, medical diagnostics systems, security systems, detection systems, lighting, and defense. The company?s DSS segment engages in the design, development, and production of electromechanical equipment, such as sonobuoys, an anti-submarine warfare device used by the United States Navy and foreign governments; and perf orms an engineering development function for the United States military and prime defense contractors on advanced technologies for defense products, and replacement of current systems. It also offers non-sonobuoy related manufacturing and services. Sparton Corporation was founded in 1900 and is headquartered in Schaumburg, Illinois.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Sparton (NYSE: SPA  ) , whose recent revenue and earnings are plotted below.

Top 5 Quality Stocks To Invest In 2014: Vornado Realty Trust(VNO)

Vornado Realty Trust is a privately owned real estate investment trust. The trust engages in investment, ownership, and management of commercial real estate. It invests in the real estate markets of United States. The trust primarily invests in office, industrial and retail properties. Vornado Realty Trust is based in New York, New York.

Advisors' Opinion:
  • [By Robert Hsu]

    And Vornado Realty Trust (NYSE: VNO) is one of these big buyers.

    The Manhattan-based real estate investment trust (REIT) owns more than 28 million square feet of high-end office, retail, and residential space in its home town. (You can tour its New York properties right here.)

  • [By CRWE]

    VORNADO REALTY TRUST (NYSE:VNO) reported that its Board of Trustees has declared a regular quarterly dividend of $0.69 per share payable on August 21, 2012 to common shareholders of record on August 10, 2012.

  • [By Ben Levisohn]

    In our view, the agreement signals that Pershing Square is willing to sell its stake in the company (17.7% direct ownership/25% total ownership), although it will be done in an orderly fashion and over a period of time. We believe that this could serve as an overhang on the stock as investors wonder if Pershing Square will exit its stake. In addition, [Vornado Realty Trust (VNO)] has stated that it is looking to liquidate its position in JCP.

Top 5 Quality Stocks To Invest In 2014: PennyMac Mortgage Investment Trust(PMT)

PennyMac Mortgage Investment Trust is based in the United States.

Advisors' Opinion:
  • [By Marc Bastow]

    PennyMac Mortgage Investment Trust (PMT), a REIT involved in mortgages and mortgage-related assets, raised its quarterly dividend 4% to 59 cents per share, payable Jan. 28 to shareholders of record as of Jan. 14. At more than 10%, PMT is the highest yielder of this week’s list of dividend stocks.
    PMT Stock Dividend Yield: 10.15%

5 Best Internet Stocks To Invest In 2014

With shares of Comcast (NASDAQ:CMCSA) trading around $43, is CMCSA an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Comcast is�is a provider of entertainment,�information, and communications products and services. The company operates in five segments: Cable Communications, Cable Networks, Broadcast Television, Filmed Entertainment, and Theme Parks. Comcast�offers television, video, high-speed Internet, and voice services to residential and business customers. It also operates NBC and Telemundo broadcast networks; provides filmed entertainment under the Universal Pictures, Focus Features, and Illumination names; and operates�theme parks, studios, and a dining, retail, and entertainment complex. The company reaches a large audience through all of its mediums. As a multimedia giant, look for Comcast to provide the products and services that consumers and companies enjoy.

Hot Net Payout Yield Companies To Watch In Right Now: Google Inc.(GOOG)

Google Inc. maintains an index of Web sites and other online content for users, advertisers, and Google network members and other content providers. It offers AdWords, an auction-based advertising program; AdSense program, which enables Web sites that are part of the Google Network to deliver ads from its AdWords advertisers; Google Display, a display advertising network that comprises the videos, text, images, and other interactive ads; DoubleClick Ad Exchange, a real-time auction marketplace for the trading of display ad space; and YouTube that provides video, interactive, and other ad formats for advertisers. The company also provides Google Mobile that optimizes Google?s applications for mobile devices in browser and downloadable form; and enables advertisers to run search ad campaigns on mobile devices, as well as Google Local that provides local information on the Web; and Google Boost for small businesses to participate in the ads auction. In addition, it offers And roid, an open source mobile software platform; Google Chrome OS, an open source operating system; Google Chrome, a Web browser; Google TV, a platform for the consumers to use the television and the Internet on a single screen; and Google Books platform to discover, search, and consume content from printed books online. Further, the company provides Google Apps, a cloud computing suite of message and collaboration tools, which includes Gmail, Google Docs, Google Calendar, and Google Sites; Google Search Appliance that offers real-time search of business and intranet applications, and public Web sites; Google Site Search, a custom search engine; Google Commerce Search for online retail enterprises; Google Checkout to make online shopping and payments streamlined and secure; Google Maps Application Programming Interface; and Google Earth Enterprise, a firewall software solution for imagery and data visualization. Google Inc. was founded in 1998 and is headquartered in Mountain View, California.

Advisors' Opinion:
  • [By Trey Thoelcke]

    There has been a rapid shift in Japan from advanced feature phones to smartphones. The main driver of that shift has been mobile games. According to App Annie, Japanese consumers spent almost four times as much on gaming apps as a year ago. Spending on devices powered by Google Inc.’s (NASDAQ: GOOG) Android has quadrupled in the year to October. And Japan is the first place in the world where Google Play spending has caught up to app spending on Apple Inc.’s (NASDAQ: AAPL) iPhones and iPads. In the rest of the world, iOS app revenue is well over double that of Google Play on an aggregate basis.

  • [By Ben Levisohn]

    Microsoft rose 3.9% to $39.55 after announcing that it would host an event on mobile and cloud computing on March 27. Pfizer, meanwhile, gained 1.6% to $31.93. US Steel surged 5.4% to $25.50 on signs of higher steel prices, while Fossil Group advanced 4.6% to $118.04 after it said it would team up with Google (GOOG) for Android Wear. Google gained 1.6% to $1,211.26.

  • [By Reuters]

    Marcio Jose Sanchez/APThe Nest smoke and carbon monoxide alarm. SAN FRANCISCO -- Nest Labs, the maker of smart thermostats that Google (GOOG) acquired for $3.2 billion, called a halt to all sales of its smoke alarms Thursday after it discovered a possible defect that could cause users to turn it off unintentionally. Nest co-founder and Chief Executive Officer Tony Faddell said that, under a unique set of circumstances the alarm's "Nest Wave" feature, which allows a user to switch off the device with a wave of the hand, could be inadvertently activated. Faddell, one of the creators of Apple's (AAPL) iPod, apologized in the blogpost for a problem that was discovered during recent laboratory testing. He added that no customer had complained so far. "We observed a unique combination of circumstances that caused us to question whether the Nest Wave ... could be unintentionally activated. This could delay an alarm going off if there was a real fire," he said. "The fact that it could even potentially happen is extremely important to me and I want to address it immediately." He didn't specify that set of circumstances. Nest will immediately disable the Wave feature -- one of many innovative design elements that has won the company and its devices acclaim -- in all smoke alarms that are Wi-Fi connected while it works on a software update to fix the possible defect. It said the fix, plus regulatory approvals, could take two to three months to complete. Customers without Wi-Fi connected devices should either disable it or return it for a full refund, the company added. Nest halted all sales of its smoke alarms to prevent customers from buying a device that would need an immediate software patch. Google announced plans in January to acquire Nest via its second largest deal, to expand into a broader array of devices and bring valuable hardware design expertise in-house. Nest gained a large following with its first thermostat -- a round, brushed-metal device wi

5 Best Internet Stocks To Invest In 2014: Inc.(AMZN), Inc. operates as an online retailer in North America and internationally. It operates retail Web sites, including and The company serves consumers through its retail Web sites and focuses on selection, price, and convenience. It also offers programs that enable sellers to sell their products on its Web sites, and their own branded Web sites. In addition, the company serves developer customers through Amazon Web Services, which provides access to technology infrastructure that developers can use to enable virtually various type of business. Further, it manufactures and sells the Kindle e-reader. Additionally, the company provides fulfillment; miscellaneous marketing and promotional agreements, such as online advertising; and co-branded credit cards., Inc. was founded in 1994 and is headquartered in Seattle, Washington.

Advisors' Opinion:
  • [By Robyn Gearey]

    Alamy "Would you like to save an extra 10 percent today?" We've all been offered store credit cards in exchange for an instant discount. For years, my answer was an automatic no. Who needs all those extra cards cluttering up their wallet ... and their credit report? But it turns out that some of these cards really can be worthwhile for frequent shoppers, with many offering extra savings, lots of rewards, and perks like free shipping on online purchases. Good credit, plus the ability (and discipline) to pay the bills in full each month, are the key to getting the benefits out of these cards -- otherwise their higher interest rates will quickly erase the savings. And even if you possess both of those attributes, you don't want to go crazy signing up for store cards; it's best to choose just one or two from stores you shop at often enough to rack up real savings. So if, like me, you find yourself at Target (TGT) every weekend, are all too familiar with Amazon's (AMZN) one-click buying option, and have kids who outgrow their Old Navy jeans every six months, then consider these store-branded card options. Note: Credit card companies are wily, and sometimes offer different deals to different customers, depending on factors like whether you're a current customer or how often you visit the store's website. The information below is based on the offers we received; if you see less favorable offers, give the company a call and ask for the better deal!

  • [By Michael Lewis]

    Tough earnings recap
    Despite the news that the two big "Office" stores are joining forces to fight back against� (NASDAQ: AMZN  ) , the market had a hard time being enthused about Office Depot's $0.02-per-share earnings in the just-ended quarter -- a drop off of two-thirds since the year-ago quarter. Wall Street was expecting earnings to drop as well, but only by one penny.

5 Best Internet Stocks To Invest In 2014: Yahoo! Inc.(YHOO)

Yahoo! Inc., together with its subsidiaries, operates as a digital media company that delivers personalized digital content and experiences through various devices worldwide. It offers online properties and services to users; and a range of marketing services to businesses. The company?s communications and communities offerings include Yahoo! Mail, Yahoo! Messenger, Yahoo! Groups, Yahoo! Answers, Flickr, and Connected TV, which provide a range of communication and social services to users and small businesses enabling users to organize into groups and share knowledge, common interests, and photos. Its search products comprise Yahoo! Search and Yahoo! Local, available free to users to navigate the Internet and discover content. The company?s marketplaces offerings and services include Yahoo! Shopping, Yahoo! Travel, Yahoo! Real Estate, Yahoo! Autos, and Yahoo! Small Business, which allow users to research specific topics, products, services, or areas of interest by review ing and exchanging information, obtaining contact details, or considering offers from providers of goods, services, or parties with similar interests. Its media offerings comprise Yahoo! Homepage, Yahoo! News, Yahoo! Sports, Yahoo! Finance, My Yahoo!, Yahoo! Toolbar, Yahoo! Entertainment & Lifestyles, Yahoo! Contributor Network, and Yahoo! Pulse, which are designed to engage users with online content and services on the Web. The company also offers marketing services, such as display and search advertising, listing-based services, and commerce-based transactions to advertisers. In addition, it provides software and platform offerings for third-party developers, advertisers, and publishers, such as Yahoo! Developer Network, Yahoo! Open Strategy, Yahoo! Application Platform, Yahoo! Updates, Yahoo! Query Language, and Yahoo! Search BOSS. The company has strategic alliances with Nokia and ABC News, Inc. Yahoo! Inc. was founded in 1994 and is headquartered in Sunnyvale, Californi a.

Advisors' Opinion:
  • [By John Casteele]

    Then, out of the blue, Sony's (NYSE: SNE  ) Sony Pictures Television unit, which holds the rights to the show, and Yahoo! (NASDAQ: YHOO  ) announced that "Community" would get its sixth season after all. Instead of appearing on one of the major streaming services, the sixth season would be an exclusive for Yahoo! Screen, the company's small-but-growing streaming component. While this is great news for the fans who will get more "Community," what does it mean for Sony and Yahoo!?

5 Best Internet Stocks To Invest In 2014: IAC/InterActiveCorp (IACI)

IAC/InterActiveCorp engages in the Internet business in the United States and internationally. The company�s Search segment develops, markets, and distributes various downloadable toolbars; provides search, reference, and content services through its destination search and other Websites, including and; and aggregates and integrates local advertising and content for distribution to publishers on Web and mobile platforms, as well as markets and distributes mobile applications through which it provides search and additional services. Its Match segment offers subscription-based and advertiser-supported online personals services through its Websites comprising,,,, and, as well as through mobile applications and Meetic-branded Websites. The company�s ServiceMagic segment offers Market Match service that matches consumers with service professionals; Exact Match service, which enables con sumers to review service professional profiles and select the service professional that meets their specific needs; and, an online directory of service professionals. This segment also offers Website design and hosting services. Its Media and Other segment operates, an online entertainment Website that targets young males; Vimeo, a Website on which users can upload, share, and view video; and, a comparison search engine. This segment also engages in the creation of video content for various distribution platforms; and operates as an Internet retailer of footwear and related apparel and accessories, as well as focuses on multimedia business. The company was formerly known as InterActiveCorp and changed its name to IAC/InterActiveCorp in July 2004. IAC/InterActiveCorp was founded in 1986 and is headquartered in New York, New York.

Advisors' Opinion:
  • [By Eric Volkman]

    Rhyu joins the company from IAC's (NASDAQ: IACI  ), where he has filled the roles of both CFO and chief administrative officer since 2011. Previous to that, he was a senior vice president at News Corp's (NASDAQ: FOXA  ) Dow Jones & Company. He also served as corporate controller for both Sirius XM Radio and GrafTech International (NYSE: GTI  ) .

  • [By Timothy Lutts, Publisher, Cabot Heritage Corporation]

    In 2004, TripAdvisor (TRIP) was purchased by conglomerate Interactive Corp (IACI), which spun off its travel businesses under the name of Expedia in 2005. In December 2011, TripAdvisor was spun off from Expedia in an IPO.

  • [By Jayson Derrick]

    InterActiveCorp (NASDAQ: IACI) announced that its CEO is stepping down from his current position to become chairman of a new operating unit. Investors cheered the management shakeup which is potentially hinting at a spinoff. Shares hit new 52 week highs of $70.44 before closing at $68.49, up 13.98 percent.

Wednesday, August 27, 2014

Top Forestry Companies For 2015

Top Forestry Companies For 2015: CDW Corp (CDW)

CDW Corporation (CDW), incorporated on May 25, 2007, is a provider of integrated information technology (IT) solutions in the United States and Canada. Its range of offerings range from discrete hardware and software products to integrated IT solutions, such as mobility, security, data center optimization, cloud computing, virtualization and collaboration. The Company has two segments: Corporate and Public. Corporate segment consists of primarily of private sector business customers. Public segment consists of government agencies and education and healthcare institutions. CDW also has two other operating segments, CDW Advanced Services and Canada (combined together as Other). The Company is a sales channel partner for many original equipment manufacturers (OEMs) and software publishers (collectively, its vendor partners), whose products it sells or include in the solutions CDW offers. The Company helps its customer base of more than 250,000 small, medium and large business , government, education and healthcare customers by delivering solutions to their IT needs.

The Companys Corporate segment is divided into a medium-large business customer channel, primarily serving customers with more than 100 employees, and a small business customer channel, primarily serving customers with up to 100 employees. The CDW Advanced Services business consists primarily of customized engineering services delivered by technology specialists and engineers and managed services that include infrastructure as a service (IaaS) offerings. The Companys product portfolio includes more than 100,000 products from more than 1,000 brands. Revenues from the sale of hardware, software, custom configuration and third-party provided services are recorded within its Corporate and Public segments.

The Companys revenue from professional services is either recognized as incurred for services billed at an hourly rate or recognized using a proporti onal pe! rformance model for services provided at a fixed fee.! Revenue from software as a service (SaaS) arrangements, IaaS arrangements, and data center services, including Internet connectivity, Web hosting, server co-location and managed services, is recognized over the period service is provided. The Company also sells certain products for which it acts as an agent. Products in this category include the sale of third-party services, warranties or software assurance (SA) or third-party-hosted SaaS and IaaS arrangements. The Company offer over 1,000 brands, from companies, such as APC, Apple, Cisco, EMC, Hewlett-Packard, IBM, Lenovo, Microsoft, NetApp, Symantec and VMware, to vendor partners, such as Drobo, Fusion-io, Meraki, Nimble Storage,, Sophos and Splunk.

The Company competes with Dimension Data, ePlus, Insight Enterprises, PC Connection, PCM, Presidio, Softchoice, World Wide Technology, Dell, Hewlett-Packard, Apple, Amazon, Newegg,,, IBM, Accenture, Staples, Office Depot and Office Max.

Advisors' Opinion:
  • [By Rich Smith]

    Just over six years after leaving the public stock markets in a $7.3 billion leveraged buyout, IT equipment supplier CDW (NASDAQ: CDW  ) is back on the Nasdaq again!

  • [By Jon C. Ogg]

    Before you consider this just to be a bit of IPO pondering, take a step back and understand that some of this list membership already hasfiled to come public or actually hasmade it public recently. Boise Cascade Co. (NYSE: BCC), CDW Corp. (NASDAQ: CDW), Coty Inc. (NYSE: COTY), Global Brass and Copper Holdings Inc. (NYSE: BRSS), Noodles & Company (NASDAQ: NDLS), Restoration Hardware Holdings Inc. (NYSE: RH), Sprouts Farmers Market Inc. (NASDAQ: SFM) and many others are on the list and have made it to the post-IPO stage in the stock market.

  • source from Top Penny Stocks For 2015:! companies! -for-2015.html

Tuesday, August 26, 2014

5 Stocks Set to Soar on Bullish Earnings

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tradable short squeeze develop as the bears rush to cover their positions to avoid big losses. Even the best short-sellers know that it's never a great idea to stay short once a bullish earnings report sparks a big short-covering rally.

Read More: Warren Buffett's Top 10 Dividend Stocks

This is why I scan the market for heavily shorted stocks that are about to report earnings. You only need to find a few of these stocks in a year to help enhance your portfolio returns -- the gains become so outsized in such a short time frame that your profits add up quickly.

That said, let's not forget that stocks are heavily shorted for a reason, so you have to use trading discipline and sound money management when playing earnings short-squeeze candidates. It's important that you don't go betting the farm on these plays and that you manage your risk accordingly. Sometimes the best play is to wait for the stock to break out following the report before you jump in to profit off a short squeeze. This way, you're letting the trend emerge after the market has digested all of the news.

Of course, sometimes the stock is going to be in such high demand that you risk missing a lot of the move by waiting. That's why it can be worth betting prior to the report -- but only if the stock is acting technically very bullish and you have a very strong conviction that it is going to rip higher. Just remember that even when you have that conviction and have done your due diligence, the stock can still get hammered if Wall Street doesn't like the numbers or guidance.

If you do decide to bet ahead of a quarter, then you might want to use options to limit your capital exposure. Heavily shorted stocks are usually the names that make the biggest post-earnings moves and have the most volatility. I personally prefer to wait until all the earnings-related news is out for a heavily shorted stock and then jump in and trade the prevailing trend.

Read More: 10 Stocks George Soros Is Buying

Veeva Systems

My first earnings short-squeeze play is cloud-based software solutions provider Veeva Systems (VEEV), which is set to release numbers on Thursday after the market close. Wall Street analysts, on average, expect Veeva Systems to report revenue of $69.28 million on earnings of 7 cents per share.

The current short interest as a percentage of the float for Veeva Systems is extremely high at 32.4%. That means that out of the 37.24 million shares in the tradable float, 12.09 million shares are sold short by the bears. This is a huge short interest on a stock with a relatively low tradable float. Any bullish earnings news could easily set off a monster short-squeeze that sends the bears scrambling to cover some of their bets.

From a technical perspective, VEEV is currently trending above its 50-day moving average and below its 200-day moving average, which is neutral trendwise. This stock recently spiked sharply higher back above its 50-day moving average with decent upside volume flows. That move has now pushed shares of VEEV within range of triggering a major breakout trade above some key near-term overhead resistance levels post-earnings.

If you're bullish on VEEV, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $24.80 to $25.08 a share and then above $26.34 a share with high volume. Look for volume on that move that registers near or above its three-month average volume of 998,267 shares. If that breakout hits post-earnings, then VEEV will set up to re-test or possibly take out its next major overhead resistance levels at $29.06 to $34 a share.

I would simply avoid VEEV or look for short-biased trades if after earnings it fails to trigger that breakout and then drops back below its 50-day moving average of $23.89 a share with high volume. If we get that move, then VEEV will set up to re-test or possibly take out its next major support levels at $21.57 to $19.51 a share. Any high-volume move below those levels will then give VEEV a chance to tag its next major support levels at $18 to $17.11 a share.

Read More: 7 Stocks Warren Buffett Is Selling in 2014

Zoes Kitchen

Another potential earnings short-squeeze trade idea is fast casual Mediterranean cuisine restaurants player Zoes Kitchen (ZOES), which is set to release its numbers on Thursday after the market close. Wall Street analysts, on average, expect Zoes Kitchen to report revenue $40.65 million on earnings of 3 cents per share.

The current short interest as a percentage of the float for Zoes Kitchen is extremely high at 33.5%. That means that out of the 8.61 million shares in the tradable float, 2.88 million shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 27.8%, or by about 627,000 shares. If the bears get caught pressing their bets into a bullish quarter, then shares of ZOES could easily explode sharply higher post-earnings as the shorts move to cover some of their trades.

From a technical perspective, ZOES is currently trending just below its 50-day moving average, which is bearish. This stock has trending sideways and consolidating for the last two months, with shares moving between $27.50 on the downside and $32.87 on the upside. Any high-volume move post-earnings above the upper-end of its recent could trigger a major breakout trade for shares of ZOES.

If you're in the bull camp on ZOES, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $32.82 to $32.87 a share with high volume. Look for volume on that move that hits near or above its three-month average volume of 399,333 shares. If that breakout gets set off post-earnings, then ZOES will set up to re-test or possibly take out its next major overhead resistance level at its all-time high of $35.59 a share. Any high-volume move above that level will then give ZOES a chance to tag or take out $40 a share.

I would simply avoid ZOES or look for short-biased trades if after earnings it fails to trigger that breakout and then drops back below some key near-term support levels at $30.11 to $28 a share with high volume. If we get that move, then ZOES will set up to re-test or possibly take out its next major support levels at $27.50 to $25.79 a share. Any high-volume move below those levels will then set up ZOES to trend below $24 a share.

Read More: 4 Stocks Breaking Out on Big Volume

Violin Memory

Another potential earnings short-squeeze candidate is memory-based storage systems player Violin Memory (VMEM), which is set to release numbers on Wednesday after the market close. Wall Street analysts, on average, expect Violin Memory to report revenue of $19.06 million on a loss of 22 cents per share.

The current short interest as a percentage of the float for Violin Memory is notable at 7.4%. That means that out of the 77.39 million shares in the tradable float, 5.76 million shares are sold short by the bears. If the bulls get the earnings news they're looking for, then shares of VMEM could easily rip sharply higher post-earnings as the shorts rush to get out of some of their positions.

From a technical perspective, VMEM is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock recently formed a double bottom chart pattern at $3.62 to $3.60 a share. Since forming that bottom, shares of VMEM have started to uptrend and move within range of triggering a big breakout trade post-earnings above some key near-term overhead resistance levels.

If you're bullish on VMEM, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $4.01 to just above $4.20 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 848,184 shares. If that breakout materializes post-earnings, then VMEM will set up to re-test or possibly take out its next major overhead resistance levels at $4.68 to $5.48 a share.

I would avoid VMEM or look for short-biased trades if after earnings it fails to trigger that breakout and then drops back below those double bottom support levels at $3.62 to $3.60 a share with high volume. If we get that move, then VMEM will set up to re-test or possibly take out its next major support levels at $3.27 to $3.04 a share.

Read More: These Toxic Stocks Could Be Poisoning Your Portfolio

Abercrombie & Fitch

Another earnings short-squeeze prospect is casual apparel specialty retailer Abercrombie & Fitch (ANF), which is set to release numbers on Thursday before the market open. Wall Street analysts, on average, expect Abercrombie & Fitch to report revenue of $909.22 million on earnings of 11 cents per share.

The current short interest as a percentage of the float for Abercrombie & Fitch is extremely high at 23%. That means that out of the 71.56 million shares in the tradable float, 16.46 million shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 9.9%, or by about 1.48 million shares. If the bears get caught pressing their bets into a strong quarter, then shares of ANF could easily spike sharply higher post-earnings as the shorts jump to cover some of their positions.

From a technical perspective, ANF is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last month, with shares moving higher from its low of $37.48 to its intraday high of $44.46 a share. During that uptrend, shares of ANF have been consistently making higher lows and higher highs, which is bullish technical price action.

If you're bullish on ANF, then I would wait until after its report and look for long-biased trades if this stock manages to break out to a new 52-week high above $44.46 a share (or above Wednesday's intraday high if greater) with high volume. Look for volume on that move that registers near or above its three-month average action of 1.85 million shares. If that breakout triggers post-earnings, then ANF will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $52 to $54 a share, or even $60 a share.

I would simply avoid ANF or look for short-biased trades if after earnings it fails to trigger that breakout and then takes out its 50-day moving average of $41.39 a share to some near-term support at $40.02 a share with high volume. If we get that move, then ANF will set up to re-test or possibly take out its next major support levels at $37.48 to $34.35 a share.

Read More: 5 Breakout Stocks Under $10 Set to Soar


My final earnings short-squeeze play is real-time operational intelligence software solutions providerSplunk (SPLK), which is set to release numbers on Thursday after the market close. Wall Street analysts, on average, expect Splunk to report revenue of $93.93 million on a loss of 2 cents per share.

The current short interest as a percentage of the float for Splunk is notable at 5.6%. That means that out of the 107.70 million shares in the tradable float, 6.03 million shares are sold short by the bears. This isn't a huge short interest, but it's more than enough to spark a solid short-covering rally post-earnings if the bulls get the earnings news they're looking for.

From a technical perspective, SPLK is currently trending below both its 50-day and 200-day moving averages, which is bearish This stock recently formed a double bottom chart pattern at $40.71 to $40.90 a share. Following that bottom, shares of SPLK have started to uptrend and break out above some near-term overhead resistance at $44.44 a share. That move is quickly pushing shares of SPLK within range of triggering another big breakout trade post-earnings.

If you're in the bull camp on SPLK, then I would wait until after its report and look for long-biased trades if this stock manages to break out above its 50-day moving average of $47.37 a share and then above more near-term resistance at $50.97 a share with high volume. Look for volume on that move that registers near or above its three-month average action of 3 million shares. If that breakout develops post-earnings, then SPLK will set up to re-test or possibly take out its next major overhead resistance levels at $56.63 to $57.60 a share, or even its 200-day moving average of $62.82 a share.

I would avoid SPLK or look for short-biased trades if after earnings it fails to trigger that breakout, and then drops back below those double bottom support levels at $40.90 to $40.71 a share and then below its 52-week low of $39.35 a share with high volume. If we get that move, then SPLK will set up to enter new 52-week-low territory, which is bearish technical price action.

To see more potential earnings short squeeze plays, check out the Earnings Short-Squeeze Plays portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.


>>5 Tech Stocks to Trade for Gains This Week

>>5 Hated Earnings Stocks You Should Love

5 Best Clean Energy Stocks To Invest In Right Now

>>5 Stocks Insiders Love Right Now

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including and

You can follow Pedone on Twitter at or @zerosum24.